There is evidence that TIMP3 participates in tumor invasion as well as preferential methylation in ovarian cancer (43), while a similar study showed that TIMP3 mRNA expression was higher in ovarian cancer patients than healthy individuals (44). This evidence concerns the gene TIMP3 and ovarian carcinoma.